Skip to main content
OpenTrials

Clinical trial condition

Bile Duct Neoplasms

Explore clinical trials studying Bile Duct Neoplasms. Study availability and eligibility vary by location and protocol.

169 public trials 27 recruiting studies
Refine in advanced search Browse all conditions

Bile Duct Neoplasms trial results

Completed

Pembrolizumab (MK-3475) Plus Gemcitabine/Cisplatin Versus Placebo Plus Gemcitabine/Cisplatin for First-Line Advanced and/or Unresectable Biliary Tract Carcinoma (BTC) (MK-3475-966/KEYNOTE-966)-China Extension Study

NCT04924062

Conditions
Adenocarcinoma, Bile Duct Diseases, Bile Duct Neoplasms, +14 more
Locations
  • Anhui Provincial Hospital ( Site 0140) Hefei, Anhui, China
  • Beijing Cancer Hospital ( Site 0138) Beijing, Beijing Municipality, China
  • Peking Union Medical College Hospital ( Site 0150) Beijing, Beijing Municipality, China
  • First Affiliated Hospital of The Third Military Medical University ( Site 0130) Chongqing, Chongqing Municipality, China
View all 22 locations
View Trial Details
Completed

Pembrolizumab (MK-3475) Plus Gemcitabine/Cisplatin Versus Placebo Plus Gemcitabine/Cisplatin for First-Line Advanced and/or Unresectable Biliary Tract Carcinoma (BTC) (MK-3475-966/KEYNOTE-966)

NCT04003636

Conditions
Adenocarcinoma, Bile Duct Diseases, Bile Duct Neoplasms, +14 more
Locations
  • University of Alabama at Birmingham Comprehensive Cancer Ctr ( Site 0016) Birmingham, Alabama, United States
  • University of California San Diego Moores Cancer Center ( Site 0008) La Jolla, California, United States
  • UCLA Hematology/Oncology - Santa Monica ( Site 0014) Los Angeles, California, United States
  • University of California - San Francisco ( Site 0030) San Francisco, California, United States
View all 185 locations
View Trial Details

Related conditions